Discontinued — last reported Q3 '25
Albemarle Catalysts — Adjusted EBITDA increased by 17.5% to $33.57M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.4%, from $35.47M to $33.57M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved operational efficiency and higher margins.
A measure of the Catalysts segment's operating profitability, excluding interest, taxes, depreciation, amortization, and...
Widely used across all industries to assess segment-level operational health.
alb_segment_catalysts_adjusted_ebitda| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.16M | $33.10M | $27.25M | $16.91M | $9.79M | $4.64M | $0.00 | $14.54M | $42.88M | $15.16M | $21.98M | $37.84M | $35.47M | $38.59M | $28.57M | $33.57M |
| QoQ Change | — | +56.4% | -17.7% | -37.9% | -42.1% | -52.7% | -100.0% | — | +194.9% | -64.6% | +45.0% | +72.1% | -6.2% | +8.8% | -26.0% | +17.5% |
| YoY Change | — | — | — | — | -53.7% | -86.0% | -100.0% | -14.0% | +337.9% | +227.1% | +51.1% | -11.8% | +134.0% | +75.6% | -24.5% | -5.4% |